⌘K

Home/Filings/4/0001181431-06-039375

4//SEC Filing

Kelly Steven 4

Accession 0001181431-06-039375

CIK 0001337223other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 4:40 PM ET

Size

6.2 KB

Accession

0001181431-06-039375

Insider Transaction Report

Form 4

Period: 2006-06-29

Innovive Pharmaceuticals, Inc.NONE

DirectorPresident and CEO

Transactions

Award
Stock Option (Right to Buy)
2006-06-29+156,301→ 156,301 total
Exercise: $3.96From: 2007-06-02Exp: 2016-06-29→ Common Stock (156,301 underlying)

Holdings

Common Stock
158,000

Footnotes (1)

[F1]The options fully vest on June 2, 2007.

Documents

1 file

4
rrd123037.xmlPrimary

Issuer

Innovive Pharmaceuticals, Inc.

CIK 0001337223

Entity typeother

Related Parties

1

filerCIK 0001339478

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 4:40 PM ET
Size: 6.2 KB

View on SEC.gov